DSPE-PEG-AA/rHDL/DCA-PEI/p53 was successful prepared with desirable and homogenous particle size, neutral surface charge, low cytotoxicity in normal cells and dual-targeting ability via the recognition of SR-BI and sigma receptor.
The anticancer activity was due to the synergistic effects of DCA and p53.